These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26672676)

  • 1. The 5As: A practical taxonomy for the determinants of vaccine uptake.
    Thomson A; Robinson K; Vallée-Tourangeau G
    Vaccine; 2016 Feb; 34(8):1018-24. PubMed ID: 26672676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature.
    Manakongtreecheep K
    Pan Afr Med J; 2017; 27(Suppl 3):23. PubMed ID: 29296158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards equity in immunisation.
    Boyce T; Gudorf A; de Kat C; Muscat M; Butler R; Habersaat KB
    Euro Surveill; 2019 Jan; 24(2):. PubMed ID: 30646979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood vaccines in Uganda and Zambia: Determinants and barriers to vaccine coverage.
    Phillips DE; Dieleman JL; Shearer JC; Lim SS
    Vaccine; 2018 Jul; 36(29):4236-4244. PubMed ID: 29885772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.
    Crawshaw AF; Farah Y; Deal A; Rustage K; Hayward SE; Carter J; Knights F; Goldsmith LP; Campos-Matos I; Wurie F; Majeed A; Bedford H; Forster AS; Hargreaves S
    Lancet Infect Dis; 2022 Sep; 22(9):e254-e266. PubMed ID: 35429463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving rates of maternal immunization: Challenges and opportunities.
    MacDougall DM; Halperin SA
    Hum Vaccin Immunother; 2016 Apr; 12(4):857-65. PubMed ID: 26552807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.
    Larson HJ; Jarrett C; Eckersberger E; Smith DM; Paterson P
    Vaccine; 2014 Apr; 32(19):2150-9. PubMed ID: 24598724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Countering vaccine hesitancy through immunization information systems, a narrative review.
    Gianfredi V; Moretti M; Lopalco PL
    Hum Vaccin Immunother; 2019; 15(11):2508-2526. PubMed ID: 30932725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of email-based reminders to increase vaccine uptake: a systematic review.
    Frascella B; Oradini-Alacreu A; Balzarini F; Signorelli C; Lopalco PL; Odone A
    Vaccine; 2020 Jan; 38(3):433-443. PubMed ID: 31806532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies implemented to address vaccine hesitancy in France: A review article.
    Fokoun C
    Hum Vaccin Immunother; 2018 Jul; 14(7):1580-1590. PubMed ID: 29608390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vaccine hesitancy and immunization coverage rates in the European Union.
    Stoeckel F; Carter C; Lyons BA; Reifler J
    Vaccine; 2021 Jun; 39(29):3935-3939. PubMed ID: 34116875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and addressing vaccine hesitancy.
    Kestenbaum LA; Feemster KA
    Pediatr Ann; 2015 Apr; 44(4):e71-5. PubMed ID: 25875982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies intended to address vaccine hesitancy: Review of published reviews.
    Dubé E; Gagnon D; MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4191-203. PubMed ID: 25896385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine hesitancy: Definition, scope and determinants.
    MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4161-4. PubMed ID: 25896383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey.
    Arrossi S; Maceira V; Paolino M; Sankaranarayanan R
    Vaccine; 2012 Mar; 30(14):2467-74. PubMed ID: 22266289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negotiating vaccine acceptance in an era of reluctance.
    Larson HJ
    Hum Vaccin Immunother; 2013 Aug; 9(8):1779-81. PubMed ID: 23896582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-economic determinants and inequities in coverage and timeliness of early childhood immunisation in rural Ghana.
    Gram L; Soremekun S; ten Asbroek A; Manu A; O'Leary M; Hill Z; Danso S; Amenga-Etego S; Owusu-Agyei S; Kirkwood BR
    Trop Med Int Health; 2014 Jul; 19(7):802-11. PubMed ID: 24766425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine hesitancy: an overview.
    Dubé E; Laberge C; Guay M; Bramadat P; Roy R; Bettinger J
    Hum Vaccin Immunother; 2013 Aug; 9(8):1763-73. PubMed ID: 23584253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies.
    Bocquier A; Ward J; Raude J; Peretti-Watel P; Verger P
    Expert Rev Vaccines; 2017 Nov; 16(11):1107-1118. PubMed ID: 28914112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.